Why is Biocon falling/rising?

As of 23-Jul, Biocon Ltd. is experiencing a price increase, currently at Rs 396.85, reflecting a rise of 9.8 points or 2.53%. The stock has shown strong performance today, outperforming its sector by 2.02% and is close to its 52-week high, just 2.28% away from Rs 405.9. Over the past month, Biocon has generated a return of 12.71%, significantly higher than the Sensex's 1.01% increase. Positive factors contributing to this rise include a high inventory turnover ratio and substantial growth in profit after tax, which has increased by 69% compared to the previous four-quarter average. Additionally, the stock is trading at a discount relative to its peers, and institutional holdings have increased, indicating strong investor confidence despite some concerns regarding the company's ability to service debt.
In the broader market context, Biocon's short-term performance has outpaced the benchmark, as evidenced by its 1-week return of 0.58% compared to the Sensex's 0.11%. While the stock has shown impressive returns over the past year at 18.07%, it is important to note that its long-term growth prospects are tempered by a high Debt to EBITDA ratio and low profitability per unit of shareholder funds. Despite these risks, the recent positive performance and institutional interest suggest a favorable outlook for the stock in the near term.